Project Manager Healthcare Biotechnology
Since July 2012
FlandersBio is the driving force to bring integrated healthcare solutions to the patient and new nutritions to the customer. Its role is to integrate all parties along the value chain to bring a concept to the market. This includes academia, companies, competence providers, cluster organisations, big pharma, regulatory bodies and government agencies, investors,... * program management clinical development * program management medical devices/diagnostics development * strategic development of the healthcare management ecosystem * development of innovation platform strategies * international partnering strategies and initiatives * project management of inward investment opportunities * support for financial pitching * networking on a regional, national and international scale.
Technical Sales Specialist and Product Management BeNeLux Flow Cytometry/T cells at Miltenyi Biotec
January 2010 --- June 2012
I am responsible for all demonstrations of flow cytometry products and T cell products in the BeNeLux. Once customers have bought the related products or instruments I do the on-site training and technical support. This means that I support the sales process and maintain good relationships with valued customers. Furthermore I am responsible to decide which campaigns, strategies and prices will be applied for these product lines within BeNeLux. This involves working closely together with the product management team in the head quarters of Miltenyi Biotec Germany and the marketing team in the BeNeLux office in Leiden.
January 2009 --- December 2009
Sales of the complete Miltenyi Biotec Research Portfolio in Flanders.
February 2004 --- November 2008
First I was a PhD student sponsored by the Federation against Cancer (Flanders), afterwards by the FWO Flanders and in the end by the University of Ghent. Doctoral thesis (1/2012): "The function and differentiation of natural killer cells." Natural killer (NK) cells are important mediators in the early defense against pathogens (infected cells) and cancer cells. Their functional activity is regulated by a battery of positive and negative signals that are generated by activating and inhibitory cell membrane receptors. This thesis investigated the role of such receptors on the development of NK cells, more specific: the role of CD27 and its ligand, CD70, in the development and activation of NK cells. The obtained results demonstrated that NK cells can develop in absence of CD27 and that, when CD27 is triggered, it is in control of shortening over-activated NK cells. In conclusion, CD27 is of major importance in immunotherapy. Promotor: Prof G. Leclercq
Result OrientedCollaborationCreative thinkingIndependenceInnovative thinkingProactivityResponsibilityService orientedStrategic thinkingTrustFlexibilityOrganizationKindness
Allergy and immunologyBiotechnologyPhases of clinical development (phase I to IV)Strategic Financial Planning
Skills and Expertise
Analytical skillsCollaborate with project teamCoordinate projectsassess the needs of the project(s)/program(s) and make changes in process, work flow and/or assignments.Manage multiple projectsProvide support for scientific and/or technical projects networking
Ph.D. in Medical Sciences from University of Ghent in 2013
in Latin-Mathematics-Science from Sint-Bavo College in 0
Bachelor in Bio-engineer Cell and Gene Biotechnology from Ghent University in 0
Master in Bio-engineer Cell and Gene Biotechnology from Ghent University in 0